BridgeBio Pharma, Inc. (BBIO)

78.23 +1.74 (+2.27%) USD  |  NASDAQ  |  Jan 02, 16:00
78.23 0.00 (0.00%) After-Hours: 17:44
More

BridgeBio Pharma Quarterly Actual Revenue

Quarterly Actual Revenue Chart

View Quarterly Actual Revenue for BBIO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Quarterly Actual Revenue Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Quarterly Actual Revenue Range, Past 5 Years

View Quarterly Actual Revenue Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Quarterly Actual Revenue Benchmarks

View Quarterly Actual Revenue Benchmarks
Start Trial
Pfizer Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade
Supernus Pharmaceuticals, Inc. Upgrade
Ionis Pharmaceuticals, Inc. Upgrade
Regeneron Pharmaceuticals, Inc. Upgrade